Hartford Alpha Capture International Value ETF
ACIV - ETF AI Analysis
Top Page
Hartford Alpha Capture International Value ETF (ACIV)
ACIV, the Hartford Alpha Capture International Value ETF, earns a solid overall rating thanks to several strong, diversified holdings like HSBC and Novartis, which bring robust financial performance, positive earnings sentiment, and supportive technical trends to the portfolio. Additional contributors such as TotalEnergies and Mitsubishi UFJ Financial Group further strengthen the fund with attractive valuations and generally favorable momentum, while a few holdings with overbought signals, high leverage, or cash flow issues (like Iberdrola and National Grid) modestly temper the outlook. The main risk factor is the fund’s exposure to companies facing leverage and cash flow challenges, which could increase volatility if market conditions worsen.
ACIV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 99.84M
- Region
- Global
- Expense Ratio
- 0.56%
- Beta
- N/A
- Issuer
- Hartford
- Inception Date
- Oct 19, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ACIV Summary
Hartford Alpha Capture International Value ETF (ACIV) invests in stocks from many countries outside the U.S., aiming to find companies that look cheap compared with their business fundamentals. It doesn’t track a specific index, but follows an international “value” theme across sectors like financials, energy, and consumer goods. Well-known holdings include Shell, Unilever, HSBC, and Novartis, giving investors broad global diversification with a focus on potentially undervalued companies. A key risk is that value stocks and international markets can be volatile, so the ETF’s price can go up or down significantly over time.
How much will it cost me?
ACIV has an expense ratio of 0.56%, which means you’ll pay about $5.60 per year for every $1,000 invested. This cost is higher than the average ETF because it’s actively managed rather than simply tracking an index.
What would affect this ETF?
ACIV could benefit if global economic growth improves, especially in Europe and Asia, supporting its diversified mix of financials, industrials, energy, and consumer companies, and if value-style stocks come back into favor as investors look for reasonably priced shares. On the downside, slower growth or recessions in major international markets, falling energy prices that hurt large holdings like Shell and TotalEnergies, or regulatory changes affecting banks, utilities, and healthcare firms could weigh on the fund’s future performance.
ACIV Top 10 Holdings
ACIV leans heavily on a mix of European energy, health care, and financial names, giving the fund a distinctly global, value-flavored profile. Shell and TotalEnergies have been rising, acting as twin engines for performance, while defensive stalwarts like Roche and Novartis add steady, health care-driven support. Iberdrola and National Grid bring a regulated utilities tilt that’s been quietly constructive. On the other side, big banks such as HSBC and UniCredit have shown more mixed, sometimes lagging momentum, occasionally putting a brake on the fund’s otherwise solid progress.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Shell (UK) | 3.93% | $3.91M | GBP 211.09B | 30.61% | 73Outperform | |
| TotalEnergies SE | 3.17% | $3.15M | EUR 177.97B | 49.76% | 78Outperform | |
| Roche Holding AG | ― | ― | ― | ― | 73Outperform | |
| Iberdrola | 2.66% | $2.64M | EUR 149.37B | 27.46% | 67Neutral | |
| HSBC Holdings | 2.49% | $2.48M | GBP 223.53B | 19.82% | 80Outperform | |
| Mitsubishi UFJ Financial Group | 2.45% | $2.44M | JPY 36.29T | 38.37% | 76Outperform | |
| UniCredit SpA | 2.43% | $2.42M | EUR 115.81B | 20.94% | 75Outperform | |
| Novartis AG | 2.34% | $2.33M | CHF 243.61B | 30.57% | 80Outperform | |
| Unilever | 2.25% | $2.24M | GBP 106.21B | -4.59% | 72Outperform | |
| DBS Group Holdings | ― | ― | ― | ― | 78Outperform |
ACIV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACIV, the sentiment is Negative. The current price of 39.41 is compared to the 20-day moving average (MA) of , compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 52.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACIV.
ACIV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $39.41 | $43.00(9.12% Upside) | $99.84M | 0.56% | 67Neutral | |
| $35.77 | $44.68(24.91% Upside) | $71.00M | 0.60% | 65Neutral | |
| $25.93 | $28.18(8.68% Upside) | $63.15M | 0.65% | 72Outperform | |
| $35.38 | $39.96(12.97% Upside) | $22.82M | 1.70% | 70Outperform | |
| $21.59 | $31.85(47.51% Upside) | $10.17M | 0.78% | 65Neutral | |
| $23.90 | $27.46(14.86% Upside) | $10.04M | 0.34% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ACIV | Hartford Alpha Capture International Value ETF | 39.41 | -0.41 | -1.04% | |
| MVPA | Miller Value Partners Appreciation ETF | 35.77 | 3.43 | 10.60% | |
| DIVL | Madison Dividend Value ETF | 25.93 | 3.34 | 14.80% | |
| WBIF | WBI BullBear Value 3000 ETF | 35.38 | 4.00 | 12.74% | |
| ARIA | ARIA Opportunities ETF | 21.59 | -3.73 | -14.75% | |
| PCOV | Principal Equity Premium Income ETF | 23.90 | -0.73 | -2.94% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
